Brett Wattles
The Latest
-
FDA Issues New Cinnamon Recall Due to Elevated Lead Levels
Federal health authorities have issued another warning to consumers regarding ground cinnamon products, following the discovery of elevated lead levels in multiple additional brands. The Food and Drug Administration (FDA) announced on Tuesday that it recommends recalls of nine brands of ground cinnamon products, with lead levels ranging from 2.03 to 7.01 parts per million (ppm). 
Federal health authorities have issued another warning to consumers regarding ground cinnamon products, following the discovery of elevated lead levels in multiple additional brands. The Food and Drug Administration (FDA) announced on Tuesday that it recommends recalls of nine brands of ground cinnamon products, with lead levels ranging from 2.03 to 7.01 parts per million (ppm). -
USDA Introduces Stringent Measures to Combat Salmonella in Poultry Products
The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) has unveiled a proposed rule aimed at significantly reducing Salmonella contamination in raw poultry products. This initiative, confirmed on July 29, represents a substantial effort to address public health concerns related to Salmonella infections, which affect millions of Americans annually. 
The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) has unveiled a proposed rule aimed at significantly reducing Salmonella contamination in raw poultry products. This initiative, confirmed on July 29, represents a substantial effort to address public health concerns related to Salmonella infections, which affect millions of Americans annually. -
FDA Approves Groundbreaking Blood Test for Colorectal Cancer Screening
Guardant Health's blood test, Shield, has received approval from the U.S. Food and Drug Administration (FDA) for colorectal cancer screening. This approval marks a major advancement in cancer detection, offering a more convenient alternative to traditional methods. Guardant Health's shares surged by 16% in premarket trading following the announcement. 
Guardant Health's blood test, Shield, has received approval from the U.S. Food and Drug Administration (FDA) for colorectal cancer screening. This approval marks a major advancement in cancer detection, offering a more convenient alternative to traditional methods. Guardant Health's shares surged by 16% in premarket trading following the announcement. -
New Blood Test Shows 90% Accuracy in Diagnosing Alzheimer’s Disease, Study Finds
A groundbreaking study from Lund University in Sweden has revealed that a new blood test can diagnose Alzheimer's disease with over 90% accuracy, marking a significant advance in the early detection and treatment of this debilitating condition. Published in the Journal of the American Medical Association, the research suggests that this test could revolutionize how Alzheimer's is diagnosed, providing a more accessible and efficient alternative to current methods. 
A groundbreaking study from Lund University in Sweden has revealed that a new blood test can diagnose Alzheimer's disease with over 90% accuracy, marking a significant advance in the early detection and treatment of this debilitating condition. Published in the Journal of the American Medical Association, the research suggests that this test could revolutionize how Alzheimer's is diagnosed, providing a more accessible and efficient alternative to current methods. -
Boeing and NASA Scramble to Fix Starliner Glitches as Return Date Remains Uncertain
NASA and Boeing provided updates on Thursday regarding the troubled Starliner spacecraft, which remains docked at the International Space Station (ISS) more than a month beyond its expected return date. Despite significant testing and troubleshooting, the timeline for the spacecraft's safe return to Earth with astronauts Sunita Williams and Butch Wilmore remains unclear. 
NASA and Boeing provided updates on Thursday regarding the troubled Starliner spacecraft, which remains docked at the International Space Station (ISS) more than a month beyond its expected return date. Despite significant testing and troubleshooting, the timeline for the spacecraft's safe return to Earth with astronauts Sunita Williams and Butch Wilmore remains unclear. -
Boar’s Head Deli Meats Recalled Nationwide Due to Listeria Contamination
Boar's Head Provisions Co. has initiated a nationwide recall of various deli products due to concerns over potential listeria contamination, a move announced by the U.S. Food Safety and Inspection Service (FSIS) on Friday. The recall affects a broad range of products, including liverwurst, ham, bologna, salami, and bacon, amounting to approximately 207,528 pounds of meat. 
Boar's Head Provisions Co. has initiated a nationwide recall of various deli products due to concerns over potential listeria contamination, a move announced by the U.S. Food Safety and Inspection Service (FSIS) on Friday. The recall affects a broad range of products, including liverwurst, ham, bologna, salami, and bacon, amounting to approximately 207,528 pounds of meat. -
CDC Reports 'Very High' COVID Levels in 21 States Amid New Variant Outbreaks
The United States is currently experiencing a significant summer surge of COVID-19, with the virus detected at "very high" levels in 21 states according to the Centers for Disease Control and Prevention's (CDC) wastewater monitoring system. The affected states include Alaska, California, Colorado, Connecticut, Florida, Hawaii, Idaho, Louisiana, Maryland, Minnesota, Nevada, New Hampshire, New Mexico, North Carolina, Oregon, Texas, Utah, Vermont, Washington, West Virginia, and Wyoming, along with the District of Columbia. 
The United States is currently experiencing a significant summer surge of COVID-19, with the virus detected at "very high" levels in 21 states according to the Centers for Disease Control and Prevention's (CDC) wastewater monitoring system. The affected states include Alaska, California, Colorado, Connecticut, Florida, Hawaii, Idaho, Louisiana, Maryland, Minnesota, Nevada, New Hampshire, New Mexico, North Carolina, Oregon, Texas, Utah, Vermont, Washington, West Virginia, and Wyoming, along with the District of Columbia. -
Widespread Produce Recall Expands Amid Listeria Fears, Affecting Major Retailers
A significant recall of various produce items has been issued across 18 states due to concerns over potential listeria contamination. Ohio-based Wiers Farm Inc. initially recalled cucumbers sold at select Walmart stores, but the recall has now expanded to include a broader range of products sold at major retailers like Aldi, Kroger, and Walmart. 
A significant recall of various produce items has been issued across 18 states due to concerns over potential listeria contamination. Ohio-based Wiers Farm Inc. initially recalled cucumbers sold at select Walmart stores, but the recall has now expanded to include a broader range of products sold at major retailers like Aldi, Kroger, and Walmart. -
Cocaine Sharks: Study Finds Drug Contamination in Predators, Warns of Dire Ecological Consequences
In a troubling revelation, marine biologists have discovered significant levels of cocaine in sharks off the coast of Rio de Janeiro. This alarming finding, detailed in a recent study, has highlighted the widespread impact of pharmaceutical and illicit drug contamination in marine ecosystems. 
In a troubling revelation, marine biologists have discovered significant levels of cocaine in sharks off the coast of Rio de Janeiro. This alarming finding, detailed in a recent study, has highlighted the widespread impact of pharmaceutical and illicit drug contamination in marine ecosystems. -
Revolutionary HIV Drug Could Slash Costs to $40 Annually: Researchers Push for Accessibility
A groundbreaking new drug, heralded as the closest approximation to an HIV vaccine to date, could drastically reduce the annual cost of HIV prevention to just $40 per patient. Currently priced at $42,250 for the first year, Lenacapavir, marketed as Sunlenca by U.S. pharmaceutical giant Gilead, has shown extraordinary promise in clinical trials. 
A groundbreaking new drug, heralded as the closest approximation to an HIV vaccine to date, could drastically reduce the annual cost of HIV prevention to just $40 per patient. Currently priced at $42,250 for the first year, Lenacapavir, marketed as Sunlenca by U.S. pharmaceutical giant Gilead, has shown extraordinary promise in clinical trials.
